loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2163780 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE) (1)

filter

01 PURDUE PHARMA (1)

filter

01 TABLET (EXTENDED-RELEASE) (1)

filter

01 150MG (1)

filter

01 Canada (1)

URL Supplier Web Content
TABLET (EXTENDED-RELEA...
150MG
CODEINE CONTIN 150MG C...
Canada
2163780
50
Narcotic (CDSA I)
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2163780

Looking for CTD TGA MCC DOSSIER APPLICATION 2163780 1

19

Purdue Pharma, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE), with a corresponding application number 2163780 and regulatory information .

proudly manufactured in the

Purdue Pharma's CODEINE CONTIN 150MG CONTROLLED RELEASE TAB TABLET (EXTENDED-RELEASE), medication with 150MG of CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE).

Post Enquiry
POST ENQUIRY